Next Article in Journal
Clustering of Dietary Patterns, Lifestyles, and Overweight among Spanish Children and Adolescents in the ANIBES Study
Previous Article in Journal
Cross-Sectional Associations between Empirically-Derived Dietary Patterns and Indicators of Disease Risk among University Students
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 8
Issue 1
10.3390/nu8010016
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Role of Chlorogenic Acids in Controlling Oxidative and Inflammatory Stress Conditions

by
Ningjian Liang
and
David D. Kitts
*
Departments of Food, Nutrition and Health, the University of British Columbia, Vancouver, BC V6T-1Z4, Canada
*
Author to whom correspondence should be addressed.
Nutrients 2016, 8(1), 16; https://doi.org/10.3390/nu8010016
Submission received: 8 October 2015 / Revised: 21 November 2015 / Accepted: 9 December 2015 / Published: 25 December 2015
Browse Figures
Versions Notes

Abstract

:
Chlorogenic acids (CGAs) are esters formed between caffeic and quinic acids, and represent an abundant group of plant polyphenols present in the human diet. CGAs have different subgroups that include caffeoylquinic, p-coumaroylquinic, and feruloyquinic acids. Results of epidemiological studies suggest that the consumption of beverages such as coffee, tea, wine, different herbal infusions, and also some fruit juices are linked to reduced risks of developing different chronic diseases. These beverages contain CGAs present in different concentrations and isomeric mixtures. The underlying mechanism(s) for specific health benefits attributed to CGAs involves mitigating oxidative stress, and hence the related adverse effects associated with an unbalanced intracellular redox state. There is also evidence to show that CGAs exhibit anti-inflammatory activities by modulating a number of important metabolic pathways. This review will focus on three specific aspects of the relevance of CGAs in coffee beverages; namely: (1) the relative composition of different CGA isomers present in coffee beverages; (2) analysis of in vitro and in vivo evidence that CGAs and individual isomers can mitigate oxidative and inflammatory stresses; and (3) description of the molecular mechanisms that have a key role in the cell signaling activity that underlines important functions.

1. Introduction

CGAs are phenolic acids with vicinal hydroxyl groups on aromatic residues that are derived from esterification of cinnamic acids, including caffeic, ferulic and p-coumaric acids with quinic acid. A number of conjugated structures, such as caffeoylquinic acids (CQA), dicaffeoylquinic acids (di-CQA), feruloylquinic acids (FQA), and p-coumaroylquinic acids (p-CoQA), exist in several isomeric forms in coffee beans. Coffee arguably is one of the most popular consumed beverages in the world and is also a very rich source of CGAs. The major CGAs in coffee include 3-caffeoylquinic acid (3-CQA), 4-caffeoylquinic acid (4-CQA), 5-caffeoylquinic acid (5-CQA), 3,4-dicaffeoylquinic acid (3,4-diCQA), 3,5-dicaffeoylquinic acid (3,5-diCQA), and 4,5-dicaffeoylquinic acid (4,5-diCQA). Additional, minor CGAs including 3-feruloylquinic acid (3-FQA), 4-feruloylquinic acid (4-FQA), 5-feruloylquinic acid (5-FQA), 3-p-coumaroylquinic acid (3-p-CoQA), 4-p-coumaroylquinic acid (4-p-CoQA), and 5-p-coumaroylquinic acid (5-p-CoQA) are also present in traceable amounts in coffee beverages [1]. CGA lactones are also present after primary thermal processing [2]. The chemical structures of major CGAs are shown in Figure 1. Besides coffee, CGAs are also present widely in beverages prepared from herbs, fruits (e.g., apples, pears, many berries), and vegetables, but consumption from these sources is 5% to 10% of that found from coffee beverage consumption [3]. The health benefits of consuming coffee, tea, fruit juice, and vegetable juice referred to in many epidemiological studies may be linked at least in part to the presence of CGAs in these food systems. There is considerable evidence available to show that CGAs exhibit many biological properties, including antibacterial, antioxidant, and anti-inflammatory activities. This review summarizes the known CGA isomer composition present in different beverages and discusses recent developments that point to potential health benefits that are linked to CGA antioxidant and anti-inflammatory attributes following consumption.
Nutrients 08 00016 g001 1024
Figure 1. Chemical structures of 3-CQA, 4-CQA, 5-CQA, 3,4-diCQA, 3,5-diCQA, 4,5-diCQA, 3-FQA, 4-FQA, 5-FQA, 3-p-CoQA, 4-p-CoQA, and 5-p-CoQA.
Figure 1. Chemical structures of 3-CQA, 4-CQA, 5-CQA, 3,4-diCQA, 3,5-diCQA, 4,5-diCQA, 3-FQA, 4-FQA, 5-FQA, 3-p-CoQA, 4-p-CoQA, and 5-p-CoQA.
Nutrients 08 00016 g001

2. CGAs Content in Coffee Beans and Coffee Brew

CGA isomer composition in green coffee beans is complex and varies in part according to a number of factors that include the specific coffee variety, the geographic location where it is grown, and the processes used in post-harvest, washing/drying procedures; all of which precedes roasting of the coffee beans. The most abundant CGA in green coffee beans is 5-CQA, which accounts for 76%–84% of the total CGAs, or approximately 10 g/100 g coffee beans [4,5]. Clifford and Ramirez-Martinez [6] measured the CGA composition in two major coffee plant species and reported that green Coffea Robusta beans grown in Santos and Sao Paulo contained a higher content of CGAs compared to green Coffea arabica beans grown in Ghana and Uganda. Later research has confirmed this finding [7]. For example, Perrone et al. [8] reported that total content of CGAs present in green Coffea canephora beans grown at Conillon was 86 milligram per gram of dry weight, whereas the total CGA contents in green Coffea arabica beans grown at Mundo Novo and Catuai Vermelho ranged from 55 to 63 to milligram per gram of dry weight. Farah et al. [2] reported that the total CGAs content in green Coffea Robusta beans was 28% higher than the average. In addition to 5-CQA, green coffee beans also contain 3- and 4-CGA, dicaffeolyquinic acids (3,4-, 3,5-, and 4,5-diCQA), feruloylquinic acids (3-, 4-, and 5-FQA), and p-coumaroylquinic (3-p-, 4-p-, and 5-p-CoQA) acids [9].
Roasting conditions significantly affect the total CGAs content and profile in processed coffee beans. High-temperature roasting will convert some CGAs into flavor and aroma compounds, or alternatively react with other chemical components in the coffee bean or brew through at least five distinct reaction pathways: namely, epimerization, decarboxylation, acyl migration, lactonization, and dehydration [10]. The final product contributes to melanoidin production in the coffee brew [11]. The idea that CGAs are a component of Maillard reaction end products, such as melanoidin products was initially based on findings that used the Folin–Ciocalteu method for quantifying total phenolics [12]. This has since been confirmed with quantitative analysis of phenolic derivatives recovered from high molecular weight components isolated from coffee brews [13]. Many, if not all, of these reactions that lead to thermal degradation of CGAs during coffee roasting are dependent on the intensity (e.g., time and temperature) of roasting. The diverse and complex nature of products produced with roasting coffee beans varys from relatively simple decarboxylation of quinic and cinnamic acids for simpler phenolic acids, to more complex formation of chlorogenic lactones, derived from dehydration of the quinic acid moiety. The latter evokes intermolecular ester bond formation when CGA is exposed to high heat treatment. Nucleophilic amine- and thio- groups from peptides are also examples of conjugate additions involving CGAs during heating coffee [10]. Hence, the more the coffee beans are roasted, the lower the content of total CGAs. Moon et al. [14] reported that around 45%–54% of CGAs were lost in the light roasted (230 °C, 12 min) beans compared to the green beans, whereas more than 99% of CGAs were lost in higher roasts (e.g., city roast, 250 °C for 17 min; French roast, 250 °C for 21 min). Although as much as 99% of CGA could be lost with the greatest roasting, 5-CQA still remained the predominant CGA isomer in roasted coffee. It is interesting that isomers 4-CQA and 3-CQA increased in some varieties of light roasted coffee beans, which could be attributed to isomerization of CGAs brought on by milder heat treatment [14]. The CGA isomer content in roasted coffee beans has been characterized in decreasing order to be: CQA > diCQA > FQA > p-CoQA [8]. CGAs composition in a coffee brew prepared from coffee beans with different roasting degrees has also been comprehensively studied. Total CGAs range from 187.7 to 295.6 mg/100 mL brew when prepared from light roasted coffee beans and from 24.2 to 41.3 mg/100 mL brew when prepared from dark roasted coffee beans [15]. Another study reported that the total CGAs in espresso coffee made from light, medium, and dark roasted coffee beans was 1060 mg/100 mL, 517 mg/100 mL, and 340 mg/100 mL, respectively [16]. Regardless of the roasting degree, the content of the total CGAs in espresso coffee from different sources ranged from 89 mg/100 mL to 811 mg/100 mL [17]. The CGA isomer contents in a commercial coffee brew also decreased in the following order, CQA > FQA > diCQA [18,19], which is different from the order reported in roasted coffee beans [8].
The specific procedures used to brew coffee beverages also affect the final content of CGAs, since many factors influence the efficiency of elution of CGAs from ground roasted coffee beans. Filtered coffee is the most widely consumed coffee brew, prepared by pouring boiled water over ground coffee beans that are stationary on a paper filter. In contrast, espresso coffeemakers apply high pressure to force a small amount of boiling water through ground coffee beans. The simplest way of making a coffee brew is by pouring boiling water over the ground coffee beans and waiting for the grounds to settle. All methods of brewing that vary in the ratio between the hot water and ground coffee beans (v/w), the turbulence, pressure, and the contact surface and contact time will produce a collective effect on the final CGAs profile. Tfouni et al. [15] reported that brews prepared by boiling water without filtration had a higher content of CGAs than the corresponding filtered ones. This result might be due to the greater contact of surfaces between the added water and the ground coffee when simply boiled, compared to the filtered method. Ludwig et al. [20] compared the CGA isomer composition in espresso coffee and filtered coffee and found that the espresso coffee brew contained relatively more CGAs compared to filtered coffee. Strong pressure applied in espresso favors the extraction efficiency of CGAs into this brew.

3. Chlorogenic Acid Content in Other Plant Sources

In addition to green and processed coffee beans being major sources of dietary CGAs, this group of phenolic compounds is also present in fruits and vegetables; again, 5-CQA is the predominant isomer. Fresh potatoes contain CGAs that range from 0.10 to 0.19 mg of 5-CGA per 100 g potato [21], which is equivalent to 90% of the total phenolic compounds present in potato tubers [22,23]. 5-CQA, 5-FQA, and 3,5-diCQA 3,4-diCQA were also detected in different varieties of the vegetable Chicorium endivia [24]. Genetically modified tomatoes with increased CGA content have also been developed to enhance antioxidant properties [25]. Popular citrus fruits such as pears and apples are additional rich sources of CGAs. The content of 5-CQA in pears ranged from 0.02 to 3.72 mg per gram of fresh fruit depending on the ripeness of the fruit [26] and type of cultivar [27]. Apples are a rich source of CGAs with the core part having the highest level (2.10 mg per gram of dry fruit), followed by the apple seed (1.10 mg per gram of dry fruit) and then apple flesh (0.48 mg per gram of dry fruit) [28]. CGAs are also present in some herbs. Wang et al. [29] studied the CGA profiles in beverages prepared from chrysanthemum, purple sweet potato stem, kuding tea, and honeysuckle flower and reported that 5-CQA and 3,5-diCQA were the dominant isomers with 3-CQA, 4-CQA, 3-FQA, 4-FQA, 5-FQA, 3,4-diCQA, and 4,5-diCQA relatively minor isomers in these beverages. CGAs are the main phenolic compounds in the tea infusions prepared from the herb Artemisia annua [30]. In summary, CGAs are widely present in the plant kingdom; many of these plants are important in the human diet. Beverages prepared from coffee beans, fruits, vegetables, and herbs constitute important dietary sources of CGAs. It is interesting to note that the “di-CGA” may contribute different taste qualities, such as producing the bitter/metallic taste found in certain coffees. The significance of this in respect to the taste profile of coffee could be particularly relevant to Robusta coffees, or blends of coffees that contain a proportion of Robusta beans and hence higher amounts of di-CGA.

4. Bioavailability and Metabolism of CGAs

In a cultured gastric epithelial model, multiple CGA isomers showed intact transfer across the gastric barrier at an acidic apical pH, with di-CQA having a relatively higher permeability coefficient compared to CQA [31]. Experiments conducted in a rat model showed that CGAs are not hydrolyzed in the stomach but are absorbed in an intact form [32]. These findings could explain the early detection of CGA in plasma within 30 min after coffee consumption. The intestinal absorption of 5-CQA has also been studied in cell culture, using the human colon carcinoma cell line Caco-2, to model the intestinal epithelium in vitro. The absorption rate for 5-CQA was 0.10% ± 0.08% at physiological concentrations, or equivalent to concentrations present in gut lumen (0.1~1 mM) [33,34]. Transepithelial transport experiments conducted with CGA using a Caco-2 intestine epithelia cultured monolayer [35] described bidirectional permeation with no transport into the basolaterial side (e.g., 99% retained on apical side), regardless of pH gradient. The permeation rate was concentration-dependent and not saturable, thus indicating passive diffusion. In addition, gut transport was inversely correlated with transepithelial electrical resistance, indicating limited passive diffusion when intestinal junctions are tight. Similar results were observed with caffeic acid, which is absorbed both from paracellular diffusion as well by a monocarboxylic acid transporter (MCT). Strong evidence exists that the majority of CGA is not absorbed in the proximal part of the gastrointestinal tract, unless transformed to caffeic and ferulic acids prior to absorption [32]. Ferulic acid is more efficiently absorbed than CGA, having a monoanionic carboxyl group and non-polar side chain or aromatic hydrophobic moiety that works well with MCT. This may not be the same for CGA, with its noted ester group likely interfering with MCT. With subsequent activity of esterases in both the small intestine mucosa and also microbial esterases in the large intestine, respectively, transformation of CGA to caffeic acid first would occur before further transformation to m-coumaric acid and phenylpropionic derivatives [36,37,38]. These main metabolites of CGA are also transported across the intestine cell by MCT. Figure 2 shows the absorption of CGA when passing through human digestive tract. Digestion–balance studies conducted in rats reported that around 9.2% ± 6.8% of CGAs was recovered in the urine 24 h after consumption of a 50 mg/kg dose of CGAs [39]. Some of the original CGA dose was recovered as simpler phenolics, such as caffeic and ferulic acids. Farah et al. [9] studied the pharmacokinetic profile and bioavailability of CGAs in healthy human subjects and found that the apparent bioavailability of CGAs from a green coffee extract was 33% ± 23%. Recovery was principally derived from CQA and diCQA, with poor absorption from FQA. Urine was not the major route for excretion of CGAs in the human trial, but smaller metabolites were recovered that suggested the metabolism and excretion of CGA, which influences the overall elimination kinetics in humans, could be quite variable and related to genetic polymorphisms. A similar result (33% ± 17% CGAs) was reported in ileostomy subjects 24 h after consumption of a high dose (2.8 mmol) of CQAs [40]. Further confirmation of this extent of digestion and absorption of CGA has come from a study where coffee CGAs recovered in plasma were quantified from subjects consuming realistic intakes. A positive dose–response describing the absorption efficiency was dependent on the intake level [41]. The bioavailability of the CGAs of coffee beverages can also be affected by various factors that are external to the dietary source. For examples, milk fat added to a coffee beverage may increase CGAs bioavailability [42] and, moreover, the concentration of CGAs present in coffee will also influence bioavailability of CGAs [43]. At present, the influence of the type of food matrix, which influences CGAs digestion and bioavailability, remains unclear and represents an interesting area for more research on factors that influence bioaccessibility of CGAs and other important dietary polyphenols.
Nutrients 08 00016 g002 1024
Figure 2. Absorption of CGA when passing through human digestive tract.
Figure 2. Absorption of CGA when passing through human digestive tract.
Nutrients 08 00016 g002

5. Antioxidant Activity of CGA Isomers

5.1. Overview of Antioxidant and Prooxidant Mechanisms and Assays for Assessing Antioxidant Activity in Vitro and in Vivo

Reactive oxygen species [44] and reactive nitrogen species (RNS) are generated endogenously by mitochondrial respiration and are contributed by exogenous exposure to oxidizing agents including ionizing radiation, heavy metals, and hypoxia [45]. The term ROS/RNS is used to include not only the superoxide anions (O2-), hydroxyl radicals (·OH), nitric oxide radicals (NO·), and peroxyl radicals (ROO·), but also non-radical oxidants, such as hypochlorous acid (HOCl), singlet oxygen (1O2), peroxylnitrite (ONOO−), and hydrogen peroxide (H2O2), which are all capable of oxidizing important biomolecules [33]. Antioxidant enzymes required to maintain a healthy redox state include: superoxide dismutase (SOD), catalase, glutathione, glutathione peroxidases, and reductase. Dietary components such as vitamin E, vitamin C, and phenolic compounds also serve as non-enzymatic antioxidants. Together, the endogenous and dietary derived antioxidants constitute our antioxidant defense system. Antioxidant phytochemicals derived from beverages constitute a major amount of dietary antioxidants with potential health benefits. In the case of CGAs, these health benefits are a result of CGAs donating hydrogen atoms to reduce free radicals and to inhibit oxidation reactions. After donating hydrogen atoms, CGAs are oxidized to respective phenoxyl radicals and these phenoxyl radicals are quickly stabilized by resonance stabilization. However, pro-oxidant activity of phytophenolics, such as caffeic acid and CGA, respectively, occur when present in systems containing redox-active metals. The redox cycling of CGA in the presence of oxygen is catalyzed by transition metals, such as Cu and Fe, to form reactive oxygen species that are capable of damaging macromolecules, such as DNA and lipids [46]. The extent of pro-oxidant activity of CGA depends on its metal reducing capacity, sequestering behavior and the oxygen-reducing capacity; the latter of which greatly influences the stability/lifetime of the CGA-derived phenoxyl radicals. Phenoxyl radicals generated from catechol ring-containing phenolics, such as caffeic acid and CGA, in the presence of Cu ions are relatively short-lived radicals, but nevertheless they can result in a pro-oxidant effect, such as DNA single strand breaks. This effect has been shown to be small for this class of polyhydroxyl phenolics, and is relatively stronger with caffeic acid than with CGA. The primary reason for this difference is that caffeic acid is a simpler p-coumaric derivative, where CGA is esterified and contains a quinic-carbohydrate moiety. This difference evokes a relatively weaker pro-oxidant effect for CGA compared to caffeic acid. Redox-inactive metals such as aluminum and zinc can also enhance the pro-oxidative effect of CGA by producing a spin-stabilizing effect on the CGA phenoxyl radical. The CGA-phenoxyl radical will then be available to induced lipid peroxidation [47]. This potential pro-oxidant activity occurs under conditions that prolong the lifetime of the phenoxyl radical.
Chemical-based assays, cell-based assays, and animal models have been established to gain different levels of understanding about the antioxidant capacity of CGAs. Mechanisms of antioxidant or pro-oxidant activity can be understood using chemical-based assays, where free radicals are artificially generated to react with tested samples under fixed conditions of time and at defined conditions. At the reaction endpoint, the amount of leftover free radicals is measured to reflect the free radical scavenging capacity of the tested sample. Various chemical reactions have been used to generate free radicals. Xanthine oxidase (XOD) utilizes hypoxanthine or xanthine as a substrate and O2 as a cofactor to generate O2-. A Fenton reaction between ferrous iron and H2O2 produces ·OH. Sodium nitroprusside breaks down to yield NO· and 2,2′-azobis(2-amidinopropane) dihydrochloride (AAPH) constantly generates ROO· at a physiologically appropriate pH.
A cell-based model offers the potential to account for transcellular and paracellular transport processes defining the absorption, and metabolism of the potential antioxidant molecule. It therefore represents and intermediate test between a purely chemical in vitro assay and an animal, in vivo, assay. There are a variety of cell-based in vitro models available for studying antioxidant activity of different food components, where chemical or physical stressors are used to induce oxidative stress prior to or during exposure of cells to a potential antioxidant compound. The response is often measured using defined biomarkers of redox status to reflect the antioxidant activity of the antioxidant test compound. A commonly used redox biomarker for quantitating response of cells to oxidative stress is the transcription factor, nuclear factor-E2-related factor 2 (Nrf2). Nrf2 is a member of the basic leucine zipper NF-E2 family and plays an essential role in the antioxidant response element-mediated expression of phase II detoxifying enzymes, including glutathione peroxidase (GPx), glutathione reductase (GR), and superoxide dismutase (SOD) [48]. Genomic DNA integrity is another important biomarker of redox status because reactive species continuously attack DNA structure and cause DNA strand breaks, crosslinks, or sister chromatid exchanges, resulting in oxidative damage of DNA [49]. Furthermore, ROS affect the DNA methylation by oxidizing key enzymes involved in the methylation process [45]. Moreover, ROS easily initiate lipid oxidation in vitro, leading to the accumulation of lipid peroxidation products such as hydroperoxides and malondialdehyde (MDA), characteristic components of the first and second stages of lipid oxidation reactions, respectively. In order to gain a more comprehensive understanding about the antioxidant activity of food components, such as polyphenols in general, and CGAs specifically, animal models have been employed to study the affinity of plant phenolic compounds to mitigate oxidative stress. Table 1 is a summary of the results obtained from chemical-based studies that have examined the antioxidant activity of CGAs. Table 2 is a summary of the cell-based and animal studies describing the antioxidant activity of CGAs reviewed in this section. In these studies, the chlorogenic acid referred to pertains mostly to 5-CQA.

5.2. Evidence from Chemical-Based Assays

All CGA isomers are potent antioxidants, as they possess one to two aromatic rings linked to hydroxyl groups and the one-electron oxidation product of CGAs formed by the reaction with free radicals is rapidly broken down to non-free radical products [50]. Chemical-based assays show that CGAs have the capacity to scavenge 1,1-diphenyl-2-picrylhydrazyl (DPPH) radicals, superoxide anions (O2-), hydroxyl radicals (·OH) [51,52], 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) radicals [53], lipid oxidation [53,54], and peroxylnitrite (ONOO-) [54]. CGAs react with difference sources of free radicals at different rate constants. The second-order rate constants for 5-CQA reacting with superoxide, hydroxyl radical, peroxyl radical, and peroxynitrite have been determined to be 0.96 ± 0.01 × 106 M−1·s−1, 3.34 ± 0.19 × 109 M−1·s−1, 1.28 ± 0.11 × 105 M−1·s−1, and 1.6 ± 0.7 × 105 M−1·s−1, respectively [54]. This result shows that the relative efficiency of 5-CQA to react with free radicals is species-specific to the radical. Another important activity of CGAs towards ROS-induced oxidative stress involves the radical damage caused to DNA, which can be quantified by measuring DNA strand breakage. Six CGA isomers, namely 3-CQA, 4-CQA, 5-CQA, 3,5-diCQA, 3,4-diCQA, and 4,5-diCQA, were shown to exhibit a protective effect against H2O2-induced DNA plasmid chromosome breaks [55]. Secondary byproducts of the oxidation reaction are also relevant in initiating a mutagenic response as a result of DNA damage. One example concerns the oxidation of chloride by H2O2, resulting in formation of HOCl, and subsequent reaction with amines to produce NH2Cl, an oxidant and potent mutagen. CGAs, specifically 5-CQA, have been shown to protect against NH2Cl-induced plasmid DNA breakage in cultured neutrophils [50]. Another example of the anti-peroxidation activity of 5-CQA comes from the protection against LDL oxidation, which is the initial step in the development of atherosclerosis. Studies based on incubating isolated LDL with oxidizing agents in vitro showed that 5-CQA was effective at mitigating both copper-induced LDL oxidation [56] and ferryl myoglobin-induced LDL oxidation [57]. These results correspond to other studies that reported reduced MDA content in brain tissues when pre-treated with 5-CQA [53].

5.3. Evidence from Cell-Based Assays

Research directed at characterizing the antioxidant capacity of CGAs using cell-based models has focused mostly on the 5-CQA isomer. This CGA isomer protects against H2O2-induced oxidative stress in human HaCaT cells [51]; it can activate Akt phosphorylation, increase the expression of FOXO family genes in mesenchymal stem cells of bone marrow [58], and reduce apoptosis in primary cortical neurons by upregulating antioxidant enzymes such as NADPH:quinine oxidoreductase 1 [59]. The protective effect of 5-CQA against oxidative stress stimulated by various oxidative stressors (e.g., t-BHP, H2O2, FeSO4) has also been studied in PC12 cells, which used multiple biomarkers such as the reduction of lipid peroxidation product, the extent of ROS formation, and GSH depletion to evaluate the utility of CGAs to prevent oxidation [60]. 5-CQA showed effectiveness in protecting against DNA damage with activity to inhibit methylation of the promoter region of the RAR beta gene through increased formation of S-adenosyl-l-homocysteine in cultured human breast cancer cells MCF-7 and MAD-MB-231, respectively [61]. 5-CQA also decreased the DNA damage by 4.49%~48.15% in human blood lymphocytes caused by X-ray irradiation [62].
In addition to these examples of chemically induced oxidation, other studies have successfully shown that CGAs are effective at reducing the damage caused by exposure to ultraviolet light (UVB) [63]. The photo-oxidation protection offered by 5-CQA in a mouse epidermal cell line [64] and human HaCaT keratinocytes [51] was related to the effects of 5-CQA to trigger induction of Nrf2 transactivation and phase II enzyme activities.
There are only a few studies that have investigated the affinity of minor CGA isomers to modulate redox status in biological systems. Three CGA isomers, namely 3-CQA, 4-CQA, and 5-CQA, have affinity to protect against H2O2-induced apoptosis in PC12 cells by suppressing the mitochondrial membrane depolarization caused by oxidative stress [65]. Recently, another research group reported that 5-CQA and 3,5-diCQA had a protective effect against t-BOOH-induced ROS generation in HepG2 cells [66].
Table
Table 1. The antioxidant activity of CGA isomers evaluated by chemical assays.
Table 1. The antioxidant activity of CGA isomers evaluated by chemical assays.
Chemical AssaysEnd-Point MeasureCGA IsomerConcentration/Exposure TimeResultsReferences
DPPH assayDPPH5-CQA5–80 μM for 3 h10%~90% inhibition on DPPH[51]
Xanthine/xanthine oxidase systemDMPO/·OOH adducts5-CQA20 μM for 2.5 min↓ 30% ·OOH[51]
FeSO4 + H2O2DMPO/·OH adducts5-CQA20 μM for 2.5 min↓ 51% ·OH[51]
FeSO4 + H2O2DMPO/·OH adducts5-CQA100–400 μM for 1 min↓ 50% to 80% ·OH[52]
ABTS assayABTS·+5-CQASerials concentration for 15 minThe ability of 100 g of CGA in scavenging ABTS·+ is equivalent to 3.7 mmol Trolox[53]
Rat brain homogenates + sodium nitroprussideMDA5-CQA1.56–6.25 μg/mLNo significant inhibition of MDA[53]
Liposome system containing AAPHMDA5-CQA0.1–0.5 mMSecond order rate of constant of the reactions of LOO· with CGA is 1.28 ± 0.11 × 105 M−1·s−1[54]
Pulse radiolysis to generate O2-O2-5-CQA0.2–0.75 mMSecond order rate of constant of the reactions of O2- with CGA is 0.96 ± 0.01 × 106 M−1·s−1[54]
Fenton-type reaction to generate ·OH·OH5-CQA0.1–0.75 mMSecond order rate of constant of the reactions of ·OH with CGA is 3.34 ± 0.19 × 109 M−1·s−1[54]
Potassium phosphate to generate ONOO-ONOO-5-CQA80 μMSecond order rate of constant of the reactions of ONOO- with CGA is 1.6 ± 0.7 × 105 M−1·s−1[54]
DPPH assayDPPH3-CQA,5 μg/mL–60 μg/mLEC50 a 3-CQA:13.4 μg/mL[55]
4-CQA,4-CQA: 13.2 μg/mL
5-CQA,5-CQA: 13.8 μg/mL
3,5-diCQA,3,5-diCQA: 9.3 μg/mL
3,4-diCQA,3,4-diCQA: 9.4 μg/mL
4,5-diCQA4,5-diCQA: 7.5 μg/mL
ABTS assayABTS·+3-CQA50 μg/mL–150 μg/mLEC50 a 3-CQA: 91.4 μg/mL[55]
4-CQA,4-CQA: 87.5 μg/mL
5-CQA,5-CQA: 91.5 μg/mL
3,5-diCQA,3,5-diCQA: 77.6 μg/mL
3,4-diCQA,3,4-diCQA: 77.4 μg/mL
4,5-diCQA4,5-diCQA: 67.3 μg/mL
FRAP assayReducing power3-CQA25–125 μg/mL4,5-diCQA > 3,5-diCQA > 3,4-diCQA > 5-CQA = 4-CQA = 3-CQA[55]
4-CQA,
5-CQA,
3,5-diCQA,
3,4-diCQA,
4,5-diCQA
DNA damage protective effect assayDNA damage3-CQA50 μg/mL↓ 43.1 to 62.4% DNA damage[55]
4-CQA,
5-CQA,
3,5-diCQA,4,5-diCQA > 3,4-diCQA > 3,5-diCQA > 5-CQA > 4-CQA > 3-CQA
3,4-diCQA,
4,5-diCQA
Plasmid pUC18 + NH2ClSupercoiled DNA, nicked circular DNA and linear duple5-CQA0.01 mM–1.23 mMPrevented a stepwise conversion of plasmid DNA form supercoiled DNA, nicked circular DNA and linear duplex DNA[50]
LDL + copperConjugated dienes5-CQA0.25–1.0 μM↑ lag time of LDL oxidation[56]
LDL + metmyoglobin + H2O2ROS5-CQA1 molar ratio to metmyoglobinEffectively blocked LDL oxidation[57]
a EC50 represents the concentration of the tested compound that results in half-maximal response.
Table
Table 2. Summary of studies that evaluated the capacity of CGAs to modulate oxidative stress in cell-based and animal-based models.
Table 2. Summary of studies that evaluated the capacity of CGAs to modulate oxidative stress in cell-based and animal-based models.
ModelEnd-Point MeasureCGA IsomerConcentration/Exposure TimeResults Compared to the Control without CGA TreatmentReferences
Cell-based assay
HaCaT cell + H2O2H2O25-CQA20 μM for 20 h↓ ROS[51]
HaCaT cell + UVBROS, DNA damage, cell viability5-CQA20 μM for 20 h↓ ROS[51]
↓ DNA damage
↑ 13% cell viability
Mesenchymal stem cell + H2O2Chromosomal condensation, cell apoptosis, ROS5-CQA10 mM for 12 h↓ Chromosomal condensation[58]
↓ Cell apoptosis
↓ ROS
Primary cortical neurons + H2O2NADPH: quinine oxido-reductase 1, Cell viability5-CQA12.5–100 μM for 1 h↑ NADPH: quinine oxido-reductase 1[59]
↑ Cell viability
Differentiated neuronal PC12 cells + H2O2Cell viability, GSH5-CQA6.2–25 μM for 2 h↑ Cell viability[60]
Attenuated GSH decrease
Differentiated neuronal PC12 cells + FeSO4Cell viability, ROS, MDA5-CQA6.2–25 μM for 2 hDid not change cell viability[60]
↓ ROS level
↓ MDA
Differentiated neuronal PC12 cell + t-BHPCell viability, GSH5-CQA6.2–25 μM for 2 h↑ Cell viability[60]
Did not change GSH level
Human breast cancer cell line MCF-7+Global methylation status5-CQA1–20 μM for 8 days↓ Global methylation[61]
Human breast cancer cell line MDA-MB-231+Global methylation status5-CQA0.2–20 μM for 3 daysDid not change the global methylation status[61]
Human breast cancer cell line T-47D+Global methylation status5-CQA20–50 μM for 2 days↓ Global methylation[61]
Human lymphocyte + X-ray radiationGenetic damage index5-CQA0.5–4 μg/mL↓ Genetic damge index by 4.49% to 48.15%[62]
Mouse epidermal cell line JB6 + UVBGST, NADPH: quinone oxido-reductase, Nrf25-CQA5–160 μM for 1 h↑ GST[64]
↑ NADPH:quinone oxido-reductase
↑ Nrf2 nuclear translocation
Differentiated neuronal PC12 cell + H2O2Mitochondrial membrane depolarization3-CQA, 4-CQA, 5-CQA10 μM for 20 minProtected mitochondrial membrane depolarization through[65]
↓ Caspase 9 activation
Human hepatoma HepG2 cell + t-BOOHROS, GSH, GPx, GR, MDA5-CQA, 3,5-diCQA10–20 μM for 20 h↓ ROS, ↑ GSH, ↑ GR, ↓ GPx, ↓ MDA[66]
Animal Models
Type 2 diabetic rat modelLipid peroxidation, GSH, VC, VE5-CQAOral administration at 5 mg/kg body weight daily for 45 days↓ Plasma lipid hydroperoxides, ↑ GSH, ↑ VC, ↑ VE[67]
Type 2 diabetic rat modelLipid peroxidation, GST, SOD, GPx, CAT 5-CQAOral administration at 5 mg/kg body weight daily for 45 days↓ Lipid oxidation, ↑ GST, ↑ SOD, ↑ GPx, ↑ CAT[68]
Methamphetamine induced oxidative stress rat modelNO, MDA, SOD, GPx5-CQAOral administration at 60 mg/kg body weight, single dose↓ NO, ↓ MDA, ↑ SOD, ↑ GPx[69]
Cd induced brain impairment rat modelSOD, CAT, GPx, GSH, VC, VE, MDA5-CQAIntragastric administration, 60 mg/kg body weight daily for 30 days↑ SOD, ↑ CAT, ↑ GPx, ↑ GSH, ↑VC, ↑ VE, ↓ MDA[70]
Scopolamine induced brain impairment rat modelMDA5-CQAOrally administered at 3–9 mg/kg body weight, single dose↓ MDA[71]
Benzopyrene induced gastrointestinal pathogenesis rat modelGST, Cytochrome P-4505-CQAEating 0.2% 5-CQA containing diet for 10 weeks↑ GST,[72]
Did not significantly change cytochrome P-450
Sodium pentobarbital induced intestinal ischemia-reperfusion rat modelVascular permeability in the small intestine5-CQADirectly administrate 1 mM into jejunum, single doseAttenuated the increased vascular permeability[73]
Azoxymethane induced colon cancer mice modelGSH/GSSG ratio5-CQAOrally administered at 0.1% 5-CQA containing diet for 20 weeks↑ Hepatic GSH/GSSG ratio[44]
UV irradiation induced erythema formation in Guinea pig and Yucatan micropigErythema5-CQAIntradermal delivery of 5-CQA at 1.49 μmol/g skinPrevented erythema formation induced by UV irradiation[74]
Gamma irradiation induced chromosomal damage in mice modelFrequencies of micro-nucleated polychromatic erythrocytes5-CQAOrally administered at 50–200 mg/kg body weight, single dose↓ Frequencies of micro-nucleated polychromatic erythrocytes[75]

5.4. Evidence from Animal-Based Assays

Given the positive data from cell culture experiments that show antioxidant properties of specific CGAs at both cellular and molecular levels, other studies conducted in rodent models have confirmed these observations by examining the redox status in animals exposed to a variety of forms of oxidative stress when fed CGAs. Furthermore, the efficacy of dietary intake of CGAs to prevent pathogenesis of a wide range of chronic disease states has been examined. One example includes the side effect of hyperglycemia that occurs with diabetes, and which leads to an increase in ROS production and increased susceptibility to oxidative stress [76]. The antioxidant activity of 5-CQA in diabetic rat models showed that feeding 5-CQA effectively reduced lipid hydroperoxide production and increased the level of non-enzymatic antioxidants such as reduced glutathione and Vitamins C and E [67,68]. Other studies have shown that 5-CQA can alleviate the oxidative stress induced by methamphetamine in rats by restoring liver SOD and GPx activities and preventing the accumulation of MDA [69].
The role of CGAs in prevention of environmental toxicity caused by heavy metal pollution, specifically cadmium (Cd), has produced data showing protection against the induction of oxidative stress in the central nervous system [77]. Pretreatment of rats with 5-CQA prior to Cd exposure significantly restored the depleted levels of GSH, vitamin C, and vitamin E, and attenuated Cd-induced MDA levels in brain tissue [70]. Other model systems used scopolamine, a muscarinic antagonist that significantly increases MDA levels in the cortex and hippocampus [78]. The scopolamine-induced amnesic mouse, an animal model to study Alzheimer’s disease, has produced data to show that 5-CQA decreased the MDA level in both the frontal cortex and the hippocampus of scopolamine-induced anemia in mice [71]. The anti-amnesic activity of 5-CQA was attributed to the affinity to reduce lipid peroxidation in addition to reducing free radical scavenging activity [71]. Former studies have also examined the role of 5-CQA to enhance detoxification of environmentally toxic residues derived from polyaromatic hydrocarbon (PAHs) exposure in mice [72]. Dietary CGAs were effective at enhancing gastrointestinal xenobiotic detoxification enzymes that are central to the detoxification of PAHs. The more recent finding that 5-CQA protects against oxidative stress through its activation of Nrf2 nuclear translocation and upregulation of cellular antioxidant enzymes [64] confirms the observation reported earlier in mice fed PAHs. ROS are also implicated in the development of ischemia/reperfusion (I/R) injury in the intestine [72] and pathogenesis of colorectal cancer. An intestinal I/R model and a colorectal cancer model were used to assess the ability of 5-CQA in alleviating oxidative stress in these sections of the gastrointestinal tract. Sato et al. [73] reported in rats with I/R injury induced by sodium pentobarbital, that dietary intake of CGA at concentrations ranging from 0.5 to 1.0 mM was effective to improve the capillary permeability of the small intestine and the capacity to reduce oxidative stress. In an azoxymethane-induced colon cancer mouse model, a 20% reduction in small intestinal GSH levels occurred, pointing to an induced oxidative stress condition. Researchers found that feeding diets containing 0.1% 5-CQA for 20 weeks attenuated azoxymethane-induced oxidative stress by bringing GSH levels back to normal levels [44].
Ultraviolet radiation and gamma radiation can also trigger the generation of ROS and consequently cause chromosomal damage in animals [63]. Intradermal delivery of 5-CQA in guinea pigs during exposure to UVB reduced photooxidation-induced damage of skin attributed to photooxidation stress [74]. Another study showed that oral administration of 5-CQA to mice at a concentration of 100 mg/kg body weight before exposure to gamma radiation significantly reduced chromosomal damage [75].
Since oxidative stress is implicated with a wide range of chronic diseases, it is challenging to understand the role of specific antioxidants in different pathological and physiological conditions. Numerous animal models have been used to identify a useful biomarker that will reflect the initiation of oxidative stress so that the quality of the antioxidant can be evaluated. Despite using different methodologies, there is strong evidence that CGAs are effective antioxidants that will protect against oxidation reactions in vivo by up-regulating redox-related nuclear transcription factors involved in the expression of antioxidant enzymes. The majority of the studies are focused on the primary isomer of CGA, 5-CQA, with a lesser amount of information available for other minor CGA isomers.

6. The Ability of CGA on Modulating Inflammatory Responses

6.1. Overview of Inflammation and Anti-Inflammatory Mechanisms

Inflammation is a physiological response to tissue injury caused by exogenous or endogenous sources. Exogenous inducers include pathogen-associated molecular patterns, virulence factors, allergens, foreign bodies, and toxic compounds [79]. Endogenous inducers of inflammation arise from cell signaling in response to damaged or malfunctioning tissues [80,81]. It is believed that a controlled inflammatory response is required to combat offending agents and result in the return of tissue homeostasis. However, a dysregulated inflammatory response could lead to the failure of effective resolution, thus leading to excessive tissue damage, resulting in acute or chronic disease states [82]. Anti-inflammatory drugs have been developed to resolve conditions of dysregulated inflammation by targeting inflammatory mediators, or modulating the activity of cell signaling cascades involved in responding to an inflammatory signal. The nuclear factor kappa B (NF-κB) pathway is a key regulator of the release of pro-inflammatory cytokines, chemokines, and adhesion molecules [83]. Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most widely used drugs for the treatment of inflammatory diseases [84]. The cyclooxygenase (COX) pathway is the major target for NSAIDs because COX catalyzes fatty acid oxygenation to produce eicosanoids, which are the cardinal signs of inflammation. Side effects of NSAIDs include a predisposition to ulcers and bleeding in the stomach and intestines. Thus, there is increased interest in searching for novel agents that may have anti-inflammatory activity, without inducing adverse side effects. Different cell lines triggered with pathogen-associated molecular patterns (lipopolysaccharide (LPS)) and pro-inflammatory cytokines (e.g., tumor necrosis factor-alpha (TNF-α), interleukin 1β (IL-1β), and interferon gamma (IFN-γ)) have been used as cell-based inflammation models to study anti-inflammatory mechanisms. Also, animal models of inflammatory bowel disease, rheumatoid arthritis, and injury-associated inflammation have been successfully used to evaluate the anti-inflammatory effect of different components, such as dietary bioactives.

6.2. CGA Suppression of Inflammation through Inhibition of Pro-Inflammatory Cytokines via Modulation of Key Transcription Factors

Inflammatory bowel disease represents a chronic relapsing of disorders occurring in the gastrointestinal tract that are characterized by intestinal inflammation and epithelial injury [85]. 5-CQA has a protective effect against intestinal-related inflammation in both cell-based and animal-based models. CGA has an anti-inflammatory effect in TNF-α and H2O2-induced human intestine epithelia Caco-2 cells by down regulating IL-8 production [86]. Studies conducted with a tea (Artemisia annua) containing CGAs showed a strong anti-inflammatory effect by decreasing the secretion of pro-inflammatory cytokines IL-8 and IL-6 in Caco-2 cells stimulated with TNF-α, LPS, IL-1β, and IFN-γ [30]. CGA also attenuated IL-1β, TNF-α, and IL-6 production in LPS-stimulated murine RAW 264.7 macrophages and in BV2 microglial cells by effectively down regulating the NF-κB pathway [87]. Previously, it has been reported that phenolic compounds lower the activity of COX and subsequently prevent the synthesis of eicosanoids [88]. A cell study conducted on murine RAW 264.7 macrophages confirmed that CGA showed anti-inflammatory activity by suppressing LPS-induced COX-2 expression via attenuating the activation of NF-κB and JNK/AP-1 signaling pathways [89]. In animal studies, the oral administration of 5-CQA protected against trinitrobenzenesulfonic acid-induced colitis in mice by reducing neutrophil infiltration and inhibition of the NF-κB pathway [48]. A similar effect was also observed in the dextran sulfate sodium-induced colitis model in mice [86] and in a carrageenan-induced paw edema model in rats [90]; in both cases a suppression of pro-inflammatory cytokines was observed.
Rheumatoid arthritis is another chronic inflammatory disorder characterized by the deterioration of cartilage and bone. Chauhan et al. [91] observed that oral administration of 40 mg/kg of 5-CQA effectively suppressed pro-inflammatory cytokines including TNF-α and IL-1β in an LPS-induced knee joint inflammation rat model. This effect was similar to the standard treatment of administering ibuprofen at 100 mg/kg.
The reduction of inflammation resulting in enhanced wound healing has also been reported for CGAs. Oral administration of 5-CQA at a dose of 50 mg/kg/day accelerated wound healing and decreased MDA and nitric oxide levels while elevating reduced-glutathione content in rats [92]. Oral administration of 5-CQA also was shown to alleviate hepatic ischemia and reperfusion-induced liver injury by reducing inflammatory responses and increasing antioxidant defense systems [93]. There is also evidence that 5-CQA can suppress IL-1β, TNF-α, and IL-6 production in CCl4-induced liver inflammation and fibrosis in rats by inhibition of NF-κB activation [94]. Table 3 is a summary of cell and animal studies on the anti-inflammatory activity of CGA.
Table
Table 3. Summary of studies that evaluated the capacity of CGAs to modulate inflammatory stress in cell-based and animal-based models.
Table 3. Summary of studies that evaluated the capacity of CGAs to modulate inflammatory stress in cell-based and animal-based models.
ModelsEnd-Point MeasureCGA IsomerConcentration/Exposure TimeResults Compared to the Control without CGA TreatmentReferences
Cell Models
Caco-2 + TNF-α and H2O2IL-85-CQA0.5–2 mM↓ IL-8[86]
Caco-2 + cocktail of inflammatory mediatorsIL-6, IL-8Mixture of all CGAs Unknown composition of CGAs for 1 h↓ IL-6, ↓ IL-8[30]
RAW 264.7 + LPSNO, IL-1β, TNF-α, cyclooxygenase-2, NF-κB, IL-65-CQA2–20 μM for 24 h↓ NO, ↓ IL-1β, ↓ TNF-α, ↓ IL-6, ↓ cyclooxygenase-2, ↓ NFκB[87]
RAW 264.7 + LPSCyclooxygenase, Prostaglandin E2, NF-κB5-CQA12.5–37.4 μg/mL for 2 h↓ Cyclooxygenase, ↓ Prostaglandin E2, ↓ NF-κB[89]
Animal Models
Trinitrobenzenesulfonic acid induced colitis mice modelMyeloperoxidase, H2O2, NF-κB5-CQAOrally administration at 20 mg/kg body weight, twice a day for 6 days↓ Myeloperoxidase, ↓ H2O2, ↓ NF-κB[48]
Dextran sulfate sodium induced colitis mice modelIL-1β, TNF-α, macrophage inflammatory protein 25-CQAOrally administration at 1 mM for 15 days↓ IL-1β, did not significantly change the levels of TNF-α and macrophage inflammatory protein 2[86]
Trinitrobenzenesulfonic acid induced colitis mice modelMyeloperoxidase, H2O2, NF-κB5-CQAOrally administration at 20 mg/kg body weight twice a day↓ Myeloperoxidase, ↓ H2O2, ↓ NF-κB[90]
Rheumatoid Arthritis rat modelIL-1β, TNF-α, T cells count, Th1 cytokines, Th2 cytokines5-CQAOrally administration at 40 mg/kg body weight↓ IL-1β, ↓ TNF-α, ↓ T cells count, ↓ Th1 cytokines, ↑ Th2 cytokines[91]
Wounds in diabetic ratWound healing speed, NO, MDA, GSH5-CQAIntraperitoneal injection at 50 mg/kg/day for 15 days↑ Wound healing speed, ↑ GSH, ↓ NO, ↓ MDA[92]
Liver injury rat modelMDA, GSH, TNF-α, NO, cyclooxygenase-2 protein increase5-CQAOrally administration at 2.5–10 mg/kg body weight, twice a day↓ MDA, ↑ GSH, ↓ TNF-α, ↓ NO, ↓ cyclooxygenase-2 protein increase[93]

7. Summary and Conclusions

CGAs, which exist in green and roasted coffee beverages as well as fruit- and vegetable-based juices, are a group of esters formed between quinic acid and some trans-cinnamic acids, such as caffeic, ferulic, and p-coumaric acids. There has been considerable interest in understanding and quantitating the bioactivity of CGAs associated with antioxidant and anti-mutagenic activities related to oxidative stress. The topic is complex with the knowledge that CGAs are not stable in high temperature processed beverages, such as coffee [1,95]. This review highlights the cellular and molecular mechanisms that explain the pharmacological benefits of consuming CGA-containing beverages. Clearly, in vitro and in vivo data indicate that 5-CQA has antioxidant activity and can alleviate oxidative stress in various disease models. This potential pro-oxidant activity occurs under conditions that prolong the lifetime of the phenoxyl radical. The majority of the evidence to date indicates an anti-inflammatory activity for 5-CQA that can be explained by its ability to down regulate pro-inflammatory cytokines, through modulation of key transcription factors. A study reported that intravenous injection with 5-CQA at high dosages caused a range of inflammatory reactions in rats [96]. However, in all reality, the CGA dose infused did not relate to a typical dietary exposure. Future research is required to assess more of the potential health benefits of CGA-containing beverages. This should involve understanding the potential bioactivities of non-5-CQA isomers and the products of CGA transformation that occur in the large intestine from microbial activity.

Acknowledgments

This work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant (DDK). Ningjian Liang is a recipient of a University of British Columbia PhD fellowship.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Matei, M.F.; Jaiswal, R.; Kuhnert, N. Investigating the Chemical Changes of Chlorogenic Acids during Coffee Brewing: Conjugate Addition of Water to the Olefinic Moiety of Chlorogenic Acids and Their Quinides. J. Agric. Food Chem. 2012, 60, 12105–12115. [Google Scholar] [CrossRef] [PubMed]
  2. Farah, A.; de Paulis, T.; Trugo, L.C.; Martin, P.R. Effect of roasting on the formation of chlorogenic acid lactones in coffee. J. Agric. Food Chem. 2005, 53, 1505–1513. [Google Scholar] [CrossRef] [PubMed]
  3. Clifford, M.N. Chlorogenic acids and other cinnamates—Nature, occurrence and dietary burden. J. Sci. Food Agric. 1999, 79, 362–372. [Google Scholar] [CrossRef]
  4. Perrone, D.; Donangelo, R.; Donangelo, C.M.; Farah, A. Modeling Weight Loss and Chlorogenic Acids Content in Coffee during Roasting. J. Agric. Food Chem. 2010, 58, 12238–12243. [Google Scholar] [CrossRef] [PubMed]
  5. Farah, A.; Donangelo, C.M. Phenolic compounds in coffee. Braz. J. Plant Physiol. 2006, 18. [Google Scholar] [CrossRef]
  6. Clifford, M.N.; Wight, J. The measurement of feruloylquinic acids and caffeoylquinic acids in coffee beans. Development of the technique and its preliminary application to green coffee beans. J. Sci. Food Agric. 1976, 27, 73–84. [Google Scholar] [CrossRef] [PubMed]
  7. Clifford, M.N.; Ramirez-Martinez, J.R. Phenols and caffeine in wet-processed coffee beans and coffee pulp. Food Chem. 1991, 40, 35–42. [Google Scholar] [CrossRef]
  8. Perrone, D.; Farah, A.; Donangelo, C.M.; de Paulis, T.; Martin, P.R. Comprehensive analysis of major and minor chlorogenic acids and lactones in economically relevant Brazilian coffee cultivars. Food Chem. 2008, 106, 859–867. [Google Scholar] [CrossRef]
  9. Farah, A.; Monteiro, M.; Donangelo, C.M.; Lafay, S. Chlorogenic Acids from Green Coffee Extract are Highly Bioavailable in Humans. J. Nutr. 2008, 138, 2309–2315. [Google Scholar] [CrossRef] [PubMed]
  10. Jaiswal, R.; Matei, M.F.; Golon, A.; Witt, M.; Kuhnert, N. Understanding the fate of chlorogenic acids in coffee roasting using mass spectrometry based targeted and non-targeted analytical strategies. Food Funct. 2012, 3, 976–984. [Google Scholar] [CrossRef] [PubMed]
  11. Schols, H.A.; Boekel, V.T.; Smit, G.; Bekedam, E.K. Incorporation of Chlorogenic Acids in Coffee Brew Melanoidins. J. Agric. Food Chem. 2008, 56, 2055–2063. [Google Scholar]
  12. Schols, H.A.; Boekel, V.T.; Smit, G.; Bekedam, E.K. High Molecular Weight Melanoidins from Coffee Brew. J. Agric. Food Chem. 2006, 54, 7658–7666. [Google Scholar]
  13. Adams, A.; Borrelli, R.C.; Fogliano, V.; de Kimpe, N. Thermal degradation studies of food melanoidins. J. Agric. Food Chem. 2005, 53, 4136–4142. [Google Scholar] [CrossRef] [PubMed]
  14. Moon, J.K.; Yoo, H.S.; Shibamoto, T. Role of Roasting Conditions in the Level of Chlorogenic Acid Content in Coffee Beans: Correlation with Coffee Acidity. J. Agric. Food Chem. 2009, 57, 5365–5369. [Google Scholar] [CrossRef] [PubMed]
  15. Tfouni, S.A.V.; Carreiro, L.B.; Teles, C.R.A.; Furlani, R.P.Z.; Cipolli, K.M.V.A.B.; Camargo, M.C.R. Caffeine and chlorogenic acids intake from coffee brew: Influence of roasting degree and brewing procedure. Int. J. Food Sci. Technol. 2014, 49, 747–752. [Google Scholar] [CrossRef]
  16. Ludwig, L.A.; Mena, P.; Calani, L.; Cid, C.; del Rio, D.; Lean, M.E.J.; Crozier, A. Variations in caffeine and chlorogenic acid contents of coffees: What are we drinking? Food Funct. 2014, 5, 1718–1726. [Google Scholar] [CrossRef] [PubMed]
  17. Crozier, T.W.M.; Stalmach, A.; Lean, M.E.J.; Crozier, A. Espresso coffees, caffeine and chlorogenic acid intake: Potential health implications. Food Funct. 2012, 3, 3–33. [Google Scholar] [CrossRef] [PubMed]
  18. Mills, C.E.; Oruna-Concha, M.J.; Mottram, D.S.; Gibson, G.R.; Spencer, J.P.E. The effect of processing on chlorogenic acid content of commercially available coffee. Food Chem. 2013, 141, 3335–3340. [Google Scholar] [CrossRef] [PubMed]
  19. Fujioka, K.; Shibamoto, T. Chlorogenic acid and caffeine contents in various commercial brewed coffees. Food Chem. 2008, 106, 217–221. [Google Scholar] [CrossRef]
  20. Ludwig, I.A.; Sanchez, L.; Caemmerer, B.; Kroh, L.W.; de Peña, M.P.; Cid, C. Extraction of coffee antioxidants: Impact of brewing time and method. Food Res. Int. 2012, 48, 57–64. [Google Scholar] [CrossRef]
  21. Dao, L.; Friedman, M. Chlorogenic acid content of fresh and processed potatoes determined by ultraviolet spectrophotometry. J. Agric. Food Chem. 1992, 40, 2152–2156. [Google Scholar] [CrossRef]
  22. Malmberg, A.G.; Theander, O. Determination of chlorogenic acid in potato tubers. J. Agric. Food Chem. 1985, 33, 549–551. [Google Scholar] [CrossRef]
  23. Griffiths, D.W.; Bain, H. Photo-induced changes in the concentrations of individual chlorogenic acid isomers in potato (Solanum tuberosum) tubers and their complexation with ferric ions. Potato Res. 1997, 40, 307–315. [Google Scholar] [CrossRef]
  24. Papetti, A.; Daglia, M.; Aceti, C.; Sordelli, B.; Spini, V.; Carazzone, C.; Gazzani, G. Hydroxycinnamic acid derivatives occurring in Cichorium endivia vegetables. J. Pharm. Biomed. Anal. 2008, 48, 472–476. [Google Scholar] [CrossRef] [PubMed]
  25. Niggeweg, R.; Martin, C.; Michael, A.J. Engineering plants with increased levels of the antioxidant chlorogenic acid. Nat. Biotechnol. 2004, 22, 746–754. [Google Scholar] [CrossRef] [PubMed]
  26. Cui, T.; Nakamura, K.; Ma, L.; Li, J.Z.; Kayahara, H. Analyses of arbutin and chlorogenic acid, the major phenolic constituents in oriental pear. J. Agric. Food Chem. 2005, 53, 3882–3887. [Google Scholar] [CrossRef] [PubMed]
  27. Li, X.; Zhang, J.Y.; Gao, W.Y.; Wang, Y.; Wang, H.Y.; Cao, J.G.; Huang, L.Q. Chemical Composition and Anti-inflammatory and Antioxidant Activities of Eight Pear Cultivars. J. Agric. Food Chem. 2012, 60, 8738–8744. [Google Scholar] [CrossRef] [PubMed]
  28. Awad, M.A.; de Jager, A.; van Westing, L.M. Flavonoid and chlorogenic acid levels in apple fruit: Characterisation of variation. Sci. Horticult. 2000, 83, 249–263. [Google Scholar] [CrossRef]
  29. Wang, Z.; Clifford, M.N.; Sharp, P. Analysis of chlorogenic acids in beverages prepared from Chinese health foods and investigation, in vitro, of effects on glucose absorption in cultured Caco-2 cells. Food Chem. 2008, 108, 369–373. [Google Scholar] [CrossRef]
  30. De Magalhaes, P.M.; Dupont, I.; Hendrickx, A.; Joly, A.; Raas, T.; Dessy, S.; Sergent, T.; Schneider, Y.J. Anti-inflammatory effect and modulation of cytochrome P450 activities by Artemisia annua tea infusions in human intestinal Caco-2 cells. Food Chem. 2012, 134, 864–871. [Google Scholar] [CrossRef] [PubMed]
  31. Farrell, T.L.; Dew, T.P.; Poquet, L.; Hanson, P.; Williamson, G. Absorption and Metabolism of Chlorogenic Acids in Cultured Gastric Epithelial Monolayers. Drug Metab. Dispoition 2011, 39, 2338–2346. [Google Scholar] [CrossRef] [PubMed]
  32. Lafay, S.; Gil-Izquierdo, A.; Manach, C.; Morand, C.; Besson, C.; Scalbert, A. Chlorogenic acid is absorbed in its intact form in the stomach of rats. J. Nutr. 2006, 136, 1192–1197. [Google Scholar] [PubMed]
  33. Halliwell, B.; Gutteridge, J.M.C. Free Radicals in Biology and Medicine; Clarendon Press: Oxford, UK, 2007. [Google Scholar]
  34. Scherbl, D.; Muentnich, S.; Richling, E. In vitro absorption studies of chlorogenic acids from coffee using the Ussing chamber model. Food Res. Int. 2014, 63, 456–463. [Google Scholar] [CrossRef]
  35. Konishi, Y.; Kobayashi, S. Transepithelial transport of chlorogenic acid, caffeic acid, and their colonic metabolites in intestinal Caco-2 cell monolayers. J. Agric. Food Chem. 2004, 52, 2518–2526. [Google Scholar] [CrossRef] [PubMed]
  36. Rechner, A.R.; Kuhnle, G.; Bremner, P.; Hubbard, G.P.; Moore, K.P.; Rice-Evans, C.A. The metabolic fate of dietary polyphenols in humans. Free Radic. Biol. Med. 2002, 33, 220–235. [Google Scholar] [CrossRef]
  37. Gonthier, M.-P.; Verny, M.-A.; Besson, C.; Rémésy, C.; Scalbert, A. Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J. Nutr. 2003, 133, 1853–1859. [Google Scholar] [PubMed]
  38. Scalbert, A.; Morand, C.; Manach, C.; Rémésy, C. Absorption and metabolism of polyphenols in the gut and impact on health. Biomed. Pharmacother. 2002, 56, 276–282. [Google Scholar] [CrossRef]
  39. Choudhury, R.; Srai, S.K.; Debnam, E.; Rice-Evans, C.A. Urinary excretion of hydroxycinnamates and flavonoids after oral and intravenous administration. Free Radic. Biol. Med. 1999, 27, 278–286. [Google Scholar] [CrossRef]
  40. Katan, M.B.; Hollman, P.C.H.; Olthof, M.R. Chlorogenic acid and caffeic acid are absorbed in humans. J. Nutr. 2001, 131, 66–71. [Google Scholar]
  41. Renouf, M.; Marmet, C.; Giuffrida, F.; Lepage, M.; Barron, D.; Beaumont, M.; Williamson, G.; Dionisi, F. Dose-response plasma appearance of coffee chlorogenic and phenolic acids in adults. Mol. Nutr. Food Res. 2014, 58, 301–309. [Google Scholar] [CrossRef] [PubMed]
  42. Tagliazucchi, D.; Helal, A.; Verzelloni, E.; Conte, A. The Type and Concentration of Milk Increase the in Vitro Bioaccessibility of Coffee Chlorogenic Acids. J. Agric. Food Chem. 2012, 60, 11056–11064. [Google Scholar] [CrossRef] [PubMed]
  43. Stalmach, A.; Williamson, G.; Crozier, A. Impact of dose on the bioavailability of coffee chlorogenic acids in humans. Food Funct. 2014, 5, 1727–1737. [Google Scholar] [CrossRef] [PubMed]
  44. Davis, S.; Bruno, R.; Rosenberg, D.; Liang, H.-Y.; Park, H. Chlorogenic Acid Differentially Alters Hepatic and Small Intestinal Thiol Redox Status Without Protecting Against Azoxymethane-Induced Colon Carcinogenesis in Mice. Nutr. Cancer 2010, 62, 362–370. [Google Scholar]
  45. Jena, N.R. DNA damage by reactive species: Mechanisms, mutation and repair. J. Biosci. 2012, 37, 503–517. [Google Scholar] [CrossRef] [PubMed]
  46. Sakihama, Y.; Cohen, M.F.; Grace, S.C.; Yamasaki, H. Plant phenolic antioxidant and prooxidant activities: Phenolics-induced oxidative damage mediated by metals in plants. Toxicology. 2002, 177, 67–80. [Google Scholar] [CrossRef]
  47. Sakihama, Y.; Yamasaki, H. Lipid Peroxidation Induced by Phenolics in Conjunction with Aluminum Ions. Biol. Plant. 2002, 45, 249–254. [Google Scholar] [CrossRef]
  48. Zatorski, H.; Sałaga, M.; Zielińska, M.; Piechota-Polańczyk, A.; Owczarek, K.; Kordek, R.; Lewandowska, U.; Chen, C.; Fichna, J. Experimental colitis in mice is attenuated by topical administration of chlorogenic acid. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2015, 388, 643–651. [Google Scholar] [CrossRef] [PubMed]
  49. Niu, Y.; DesMarais, T.L.; Tong, Z.; Yao, Y.; Costa, M. Oxidative stress alters global histone modification and DNA methylation. Free Radic. Biol. Med. 2015, 82, 22–28. [Google Scholar] [CrossRef] [PubMed]
  50. Shibata, H.; Sakamoto, Y.; Oka, M.; Kono, Y. Natural antioxidant, chlorogenic acid, protects against DNA breakage caused by monochloramine. Biosci. Biotechnol. Biochem. 1999, 63, 1295–1297. [Google Scholar] [CrossRef] [PubMed]
  51. Cha, J.W.; Piao, M.J.; Kim, K.C.; Yao, C.W.; Zheng, J.; Kim, S.M.; Hyun, C.L.; Ahn, Y.S.; Hyun, J.W. The Polyphenol Chlorogenic Acid Attenuates UVB-mediated Oxidative Stress in Human HaCaT Keratinocytes. Biomol. Ther. 2014, 22, 136–142. [Google Scholar] [CrossRef] [PubMed]
  52. Zhang, L.-Y.; Cosma, G.; Gardner, H.; Vallyathan, V.; Castranova, V. Effect of chlorogenic acid on hydroxyl radical. Mol. Cell. Biochem. 2003, 247, 205–210. [Google Scholar] [CrossRef]
  53. Oboh, G.; Agunloye, O.M.; Akinyemi, A.J.; Ademiluyi, A.O.; Adefegha, S.A. Comparative Study on the Inhibitory Effect of Caffeic and Chlorogenic Acids on Key Enzymes Linked to Alzheimer’s Disease and Some Pro-oxidant Induced Oxidative Stress in Rats’ Brain-in Vitro. Neurochem. Res. 2013, 38, 413–419. [Google Scholar] [CrossRef] [PubMed]
  54. Kono, Y.; Kobayashi, K.; Tagawa, S.; Adachi, K.; Ueda, A.; Sawa, Y.; Shibata, H. Antioxidant activity of polyphenolics in diets. BBA Gen. Subj. 1997, 1335, 335–342. [Google Scholar] [CrossRef]
  55. Xu, J.G.; Hu, Q.P.; Liu, Y. Antioxidant and DNA-Protective Activities of Chlorogenic Acid Isomers. J. Agric. Food Chem. 2012, 60, 11625–11630. [Google Scholar] [CrossRef] [PubMed]
  56. Gordon, M.H.; Wishart, K. Effects of Chlorogenic Acid and Bovine Serum Albumin on the Oxidative Stability of Low Density Lipoproteins in Vitro. J. Agric. Food Chem. 2010, 58, 5828–5833. [Google Scholar] [CrossRef] [PubMed]
  57. Laranjinha, J.; Vieira, O.; Almeida, L.; Madeira, V. Inhibition of metmyoglobin/H2O2-dependent low density lipoprotein lipid peroxidation by naturally occurring phenolic acids. Biochem. Pharmacol. 1996, 51, 395–402. [Google Scholar] [CrossRef]
  58. Li, S.Y.; Bian, H.T.; Liu, Z.; Wang, Y.; Dai, J.H.; He, W.F.; Liao, X.G.; Liu, R.R.; Luo, J. Chlorogenic acid protects MSCs against oxidative stress by altering FOXO family genes and activating intrinsic pathway. Eur. J. Pharmacol. 2012, 674, 65–72. [Google Scholar] [CrossRef] [PubMed]
  59. Kim, H.W.; Kim, J.; Kim, J.; Lee, K.W.; Lee, H.J.; Lee, S.; Shim, J.; Jang, Y.J.; Yang, H.; Park, J.; et al. Caffeinated coffee, decaffeinated coffee, and the phenolic phytochemical chlorogenic acid up-regulate NQO1 expression and prevent H2O2-induced apoptosis in primary cortical neurons. Neurochem. Int. 2012, 60, 466–474. [Google Scholar] [CrossRef] [PubMed]
  60. Pavlica, S.; Gebhardt, R. Protective effects of ellagic and chlorogenic acids against oxidative stress in PC12 cells. Free Radic. Res. 2005, 39, 1377–1390. [Google Scholar] [CrossRef] [PubMed]
  61. Lee, W.J.; Zhu, B.T. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 2006, 27, 269–277. [Google Scholar] [CrossRef] [PubMed]
  62. Cinkilic, N.; Cetintas, S.K.; Zorlu, T.; Vatan, O.; Yilmaz, D.; Cavas, T.; Tunc, S.; Ozkan, L.; Bilaloglu, R. Radioprotection by two phenolic compounds: Chlorogenic and quinic acid, on X-ray induced DNA damage in human blood lymphocytes in vitro. Food Chem. Toxicol. 2013, 53, 359–363. [Google Scholar] [CrossRef] [PubMed]
  63. Heck, D.E.; Vetrano, A.M.; Mariano, T.M.; Laskin, J.D. UVB light stimulates production of reactive oxygen species—Unexpected role for catalase. J. Biol. Chem. 2003, 278, 22432–22436. [Google Scholar] [CrossRef] [PubMed]
  64. Feng, R.T.; Lu, Y.J.; Bowman, L.L.; Qian, Y.; Castranova, V.; Ding, M. Inhibition of activator protein-1, NF-kappa B, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J. Biol. Chem. 2005, 280, 27888–27895. [Google Scholar] [CrossRef] [PubMed]
  65. Park, J.B. Isolation and quantification of major chlorogenic acids in three major instant coffee brands and their potential effects on H2O2-induced mitochondrial membrane depolarization and apoptosis in PC-12 cells. Food Funct. 2013, 4, 1632–1638. [Google Scholar] [CrossRef] [PubMed]
  66. Baeza, G.; Amigo-Benavent, M.; Sarria, B.; Goya, L.; Mateos, R.; Bravo, L. Green coffee hydroxycinnamic acids but not caffeine protect human HepG2 cells against oxidative stress. Food Res. Int. 2014, 62, 1038–1046. [Google Scholar] [CrossRef]
  67. Karthikesan, K.; Pari, L.; Menon, V.P. Protective effect of tetrahydrocurcumin and chlorogenic acid against streptozotocin–nicotinamide generated oxidative stress induced diabetes. J. Funct. Foods 2010, 2, 134–142. [Google Scholar] [CrossRef]
  68. Pari, L.; Karthikesan, K.; Menon, V.P. Comparative and combined effect of chlorogenic acid and tetrahydrocurcumin on antioxidant disparities in chemical induced experimental diabetes. Mol. Cell. Biochem. 2010, 341, 109–117. [Google Scholar] [CrossRef] [PubMed]
  69. Koriem, K.M.M.; Soliman, R.E. Chlorogenic and caftaric acids in liver toxicity and oxidative stress induced by methamphetamine. J. Toxicol. 2014, 2014, 583494. [Google Scholar] [CrossRef] [PubMed]
  70. Hao, M.-L.; Pan, N.; Zhang, Q.-H.; Wang, X.-H. Therapeutic efficacy of chlorogenic acid on cadmium-induced oxidative neuropathy in a murine model. Exp. Ther. Med. 2015, 9, 1887–1894. [Google Scholar] [CrossRef] [PubMed]
  71. Kwon, S.-H.; Lee, S.-Y.; Lee, C.-K.; Lee, H.-K.; Kim, H.-C.; Kim, Y.-B.; Kim, J.-A.; Hong, S.-I.; Jo, T.-H.; Park, Y.-I.; et al. Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice. Eur. J. Pharmacol. 2010, 649, 210–217. [Google Scholar] [CrossRef] [PubMed]
  72. Kitts, D.D.; Wijewickreme, A.N. Effect of dietary caffeic and chlorogenic acids on in vivo xenobiotic enzyme-systems. Plant Foods Hum. Nutr. 1994, 45, 287–298. [Google Scholar] [CrossRef] [PubMed]
  73. Sato, Y.; Itagaki, S.; Kurokawa, T.; Ogura, J.; Kobayashi, M.; Hirano, T.; Sugawara, M.; Iseki, K. In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid. Int. J. Pharm. 2011, 403, 136–138. [Google Scholar] [CrossRef] [PubMed]
  74. Kitagawa, S.; Yoshii, K.; Morita, S.; Teraoka, R. Efficient Topical Delivery of Chlorogenic Acid by an Oil-in-Water Microemulsion to Protect Skin against UV-Induced Damage. Chem. Pharm. Bull. 2011, 59, 793–796. [Google Scholar] [CrossRef] [PubMed]
  75. Abraham, S.K.; Sarma, L.; Kesavan, P.C. Protective effects of chlorogenic acid, curcumin and β-carotene against γ-radiation-induced in vivo chromosomal damage. Mutat. Res. Lett. 1993, 303, 109–112. [Google Scholar] [CrossRef]
  76. Bonnefont-Rousselot, D. Glucose and reactive oxygen species. Curr. Opin. Clin. Nutr. Metab. Care 2002, 5, 561–568. [Google Scholar] [CrossRef] [PubMed]
  77. Kasprzak, K.S. Oxidative DNA and protein damage in metal-induced toxicity and carcinogenesis. Free Radic. Biol. Med. 2002, 32, 958–967. [Google Scholar] [CrossRef]
  78. Jeong, E.J.; Lee, K.Y.; Kim, S.H.; Kim, Y.C.; Sung, S.H. Cognitive-enhancing and antioxidant activities of iridoid glycosides from Scrophularia buergeriana in scopolamine-treated mice. Eur. J. Pharmacol. 2008, 588, 78–84. [Google Scholar] [CrossRef] [PubMed]
  79. Medzhitov, R.; Janeway, C.A. Innate Immunity: The Virtues of a Nonclonal System of Recognition; Elsevier Inc.: Cambridge, UK, 1997; Volume 91, pp. 295–298. [Google Scholar]
  80. Medzhitov, R. Origin and physiological roles of inflammation. Nature 2008, 454, 428–435. [Google Scholar] [CrossRef] [PubMed]
  81. Nathan, C. Neutrophils and immunity: Challenges and opportunities. Nat. Rev. Immunol. 2006, 6, 173–182. [Google Scholar] [CrossRef] [PubMed]
  82. Elenkov, I.J.; Iezzoni, D.G.; Daly, A.; Harris, A.G.; Chrousos, G.P. Cytokine Dysregulation, Inflammation and Well-Being. Neuroimmunomodulation 2005, 12, 255–269. [Google Scholar] [CrossRef] [PubMed]
  83. Lawrence, T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb. Perspect. Biol. 2009, 1. [Google Scholar] [CrossRef] [PubMed]
  84. Laine, L. Approaches to Nonsteroidal Anti-inflammatory Drug Use in the High-Risk Patient. Gastroenterology 2001, 120, 594–606. [Google Scholar] [CrossRef] [PubMed]
  85. Neurath, M.F. Cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 2014, 14, 329–342. [Google Scholar] [CrossRef] [PubMed]
  86. Shin, H.S.; Satsu, H.; Bae, M.J.; Zhao, Z.H.; Ogiwara, H.; Totsuka, M.; Shimizu, M. Anti-inflammatory effect of chlorogenic acid on the IL-8 production in Caco-2 cells and the dextran sulphate sodium-induced colitis symptoms in C57BL/6 mice. Food Chem. 2015, 168, 167–175. [Google Scholar] [CrossRef] [PubMed]
  87. Hwang, S.J.; Kim, Y.-W.; Park, Y.; Lee, H.-J.; Kim, K.-W. Anti-inflammatory effects of chlorogenic acid in lipopolysaccharide-stimulated RAW 264.7 cells. Inflamm. Res. 2014, 63, 81–90. [Google Scholar] [CrossRef] [PubMed]
  88. Mitjavila, M.T.; Moreno, J.J. The effects of polyphenols on oxidative stress and the arachidonic acid cascade. Implications for the prevention/treatment of high prevalence diseases. Biochem. Pharmacol. 2012, 84, 1113–1122. [Google Scholar] [CrossRef] [PubMed]
  89. Shan, J.; Fu, J.; Zhao, Z.; Kong, X.; Huang, H.; Luo, L.; Yin, Z. Chlorogenic acid inhibits lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 cells through suppressing NF-κB and JNK/AP-1 activation. Int. Immunopharmacol. 2009, 9, 1042–1048. [Google Scholar] [CrossRef] [PubMed]
  90. Chauhan, P.S.; Satti, N.K.; Sharma, V.K.; Dutt, P.; Avtar, K.; Bani, S. Amelioration of inflammatory responses by chlorogenic acid via suppression of pro-inflammatory mediators. J. Appl. Pharm. Sci. 2011, 1, 67–75. [Google Scholar]
  91. Chauhan, P.S.; Satti, N.K.; Sharma, P.; Sharma, V.K.; Suri, K.A.; Bani, S. Differential Effects of Chlorogenic Acid on Various Immunological Parameters Relevant to Rheumatoid Arthritis. Phytother. Res. 2012, 26, 1156–1165. [Google Scholar] [CrossRef] [PubMed]
  92. Bagdas, D.; Etoz, B.C.; Gul, Z.; Ziyanok, S.; Inan, S.; Turacozen, O.; Gul, N.Y.; Topal, A.; Cinkilic, N.; Tas, S.; et al. In vivo systemic chlorogenic acid therapy under diabetic conditions: Wound healing effects and cytotoxicity/genotoxicity profile. Food Chem. Toxicol. 2015, 81, 54–61. [Google Scholar] [CrossRef] [PubMed]
  93. Yun, N.; Kang, J.W.; Lee, S.M. Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver: Molecular evidence of its antioxidant and anti-inflammatory properties. J. Nutr. Biochem. 2012, 23, 1249–1255. [Google Scholar] [CrossRef] [PubMed]
  94. Shi, H.T.; Dong, L.; Jiang, J.; Zhao, J.H.; Zhao, G.; Dang, X.Y.; Lu, X.L.; Jia, M. Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. Toxicology 2013, 303, 107–114. [Google Scholar] [CrossRef] [PubMed]
  95. Liu, Y.; Kitts, D.D. Confirmation that the Maillard reaction is the principle contributor to the antioxidant capacity of coffee brews. Food Res. Int. 2011, 44, 2418–2424. [Google Scholar] [CrossRef]
  96. Du, W.Y.; Chang, C.; Zhang, Y.; Liu, Y.Y.; Sun, K.; Wang, C.S.; Wang, M.X.; Liu, Y.; Wang, F.; Fan, J.Y.; et al. High-dose chlorogenic acid induces inflammation reactions and oxidative stress injury in rats without implication of mast cell degranulation. J. Ethnopharmacol. 2013, 147, 74–83. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Liang, N.; Kitts, D.D. Role of Chlorogenic Acids in Controlling Oxidative and Inflammatory Stress Conditions. Nutrients 2016, 8, 16. https://doi.org/10.3390/nu8010016

AMA Style

Liang N, Kitts DD. Role of Chlorogenic Acids in Controlling Oxidative and Inflammatory Stress Conditions. Nutrients. 2016; 8(1):16. https://doi.org/10.3390/nu8010016

Chicago/Turabian Style

Liang, Ningjian, and David D. Kitts. 2016. "Role of Chlorogenic Acids in Controlling Oxidative and Inflammatory Stress Conditions" Nutrients 8, no. 1: 16. https://doi.org/10.3390/nu8010016

APA Style

Liang, N., & Kitts, D. D. (2016). Role of Chlorogenic Acids in Controlling Oxidative and Inflammatory Stress Conditions. Nutrients, 8(1), 16. https://doi.org/10.3390/nu8010016

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop